Literature DB >> 18293174

Effect of severity of intervertebral disc injury on mesenchymal stem cell-based regeneration.

Grace Ho1, Victor Y L Leung, Kenneth M C Cheung, Danny Chan.   

Abstract

Mesenchymal stem cell (MSC) implantation has been shown previously to arrest disc degeneration. This study aims to assess the effect of severity of disc degeneration on the ability of MSCs to arrest the degeneration. Disc degeneration was induced in New Zealand white rabbits at lumbar levels by annular puncture. The degeneration was allowed to progress for 1 month (early group) or 7 months (late group), followed by intradiscal injection of autologous MSCs. For disc levels that received MSCs treatment, 1 x 10(5) BrdU-labeled MSCs were injected per disc level. For the early group, MSC-injection had no significant effects on disc height or the progression of disc degeneration. For the late group, although the MSC-injected discs displayed lower disc heights than the control discs, they were significantly less degenerated together with near normal level of proteoglycan in localized areas. This is the first pilot study to demonstrate that severity of degeneration can influence the therapeutic effect of MSCs. Future studies of cell-based intervertebral disc regeneration should be carefully controlled in the context of stage of disc degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293174     DOI: 10.1080/03008200701818595

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  29 in total

1.  The fabrication of cryogel scaffolds incorporated with poloxamer 407 for potential use in the regeneration of the nucleus pulposus.

Authors:  Nicholas A Temofeew; Katherine R Hixon; Sarah H McBride-Gagyi; Scott A Sell
Journal:  J Mater Sci Mater Med       Date:  2017-01-31       Impact factor: 3.896

2.  The effects of needle puncture injury on microscale shear strain in the intervertebral disc annulus fibrosus.

Authors:  Arthur J Michalek; Mark R Buckley; Lawrence J Bonassar; Itai Cohen; James C Iatridis
Journal:  Spine J       Date:  2010-10-23       Impact factor: 4.166

Review 3.  Scaffolding in tissue engineering: general approaches and tissue-specific considerations.

Authors:  B P Chan; K W Leong
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

Review 4.  Intervertebral disc transplantation: a biological approach to motion preservation.

Authors:  Keith D K Luk; D K Ruan
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

Review 5.  Stem cell therapy for intervertebral disc regeneration: obstacles and solutions.

Authors:  Daisuke Sakai; Gunnar B J Andersson
Journal:  Nat Rev Rheumatol       Date:  2015-02-24       Impact factor: 20.543

Review 6.  Stem cells sources for intervertebral disc regeneration.

Authors:  Gianluca Vadalà; Fabrizio Russo; Luca Ambrosio; Mattia Loppini; Vincenzo Denaro
Journal:  World J Stem Cells       Date:  2016-05-26       Impact factor: 5.326

Review 7.  The role of stem cell therapies in degenerative lumbar spine disease: a review.

Authors:  David Oehme; Tony Goldschlager; Jeffrey V Rosenfeld; Peter Ghosh; Graham Jenkin
Journal:  Neurosurg Rev       Date:  2015-03-07       Impact factor: 3.042

Review 8.  Cell therapy for the degenerating intervertebral disc.

Authors:  Wei Tong; Zhouyu Lu; Ling Qin; Robert L Mauck; Harvey E Smith; Lachlan J Smith; Neil R Malhotra; Martin F Heyworth; Franklin Caldera; Motomi Enomoto-Iwamoto; Yejia Zhang
Journal:  Transl Res       Date:  2016-11-28       Impact factor: 7.012

9.  Disc cell therapy with bone-marrow-derived autologous mesenchymal stromal cells in a large porcine disc degeneration model.

Authors:  G W Omlor; S Lorenz; A G Nerlich; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2018-08-23       Impact factor: 3.134

10.  An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue.

Authors:  Christine L Le Maitre; Pauline Baird; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-02-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.